Expression of SART3 antigen and induction of CTLs by SART3-derived peptides in breast cancer patients

British Journal of Cancer

Volumn 84, Issue 7, 2001, Pages 915-919

  Suefuji, Y ^a   Sasatomi, T ^a   Shichijo, S ^b   Nakagawa, S ^b   Deguchi, H ^b   Koga, T ^b   Kameyama, T ^a   Itoh, K ^b  

^a Immunology

^b KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Breast cancer; Cancer vaccine; HLA A24; Immunotherapy; SART3 antigen

Indexed keywords

ESTROGEN RECEPTOR; HLA A ANTIGEN; HLA A24 ANTIGEN; PROGESTERONE RECEPTOR; SART3 TUMOR REJECTION ANTIGEN; TUMOR REJECTION ANTIGEN; UNCLASSIFIED DRUG;

ANTIGEN DETECTION; ANTIGEN EXPRESSION; ARTICLE; BREAST CANCER; BREAST CELL; CANCER CELL CULTURE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; HUMAN; HUMAN CELL; IMMUNOTHERAPY; MONONUCLEAR CELL; PRIORITY JOURNAL; WESTERN BLOTTING;

ADENOCARCINOMA; ANTIGENS, NEOPLASM; BREAST NEOPLASMS; HLA-A ANTIGENS; HUMANS; IMMUNOTHERAPY; LEUKOCYTES, MONONUCLEAR; LYMPHOCYTE ACTIVATION; PEPTIDE FRAGMENTS; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; RNA-BINDING PROTEINS; T-LYMPHOCYTES, CYTOTOXIC; TUMOR CELLS, CULTURED;

EID: 0035815211     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1054/bjoc.2000.1690     Document Type: Article

References (23)

1. Tumor-specific and HLA-A2-restricted cytolysis tumor-associated lymphocytes in human metastatic breast cancer
2. Human gene MAGE-3 codes for an antigen recognized on a melanoma by autologous cytolytic T lymphocytes
3. Allele and haplotype frequencies for HLA and complement loci in various ethnic groups
4. The expression of tumor-rejection antigens of MAGE genes
5. Identification of the immunodominant peptides of the MART-I human melanoma antigen recognized by the majority of HLA-A2-restricted tumor infiltrating lymphocytes
6. Recognition of multiple epitopes in the human melanoma antigen gp100 by tumor-infiltrating T lymphocytes associated with in vivo tumor regression
7. Expression of the SART1 tumor rejection antigen in breast cancer
8. Identification of a SART1-derived peptide capable of inducing HLA-A24-restricted and tumor-specific cytotoxic T lymphocytes
9. Tumor regressions observed in patients with metastatic melanoma treated with an antigenic peptide encoded by gone MAGE-3 and presented by HLA-A1
10. Expression of the SART3 tumor-rejection antigen in brain tumors and induction of cytotoxic T lymphocyres by its peptide
11. Vaccination of melanoma patients with peptide- or tumor lysate-pulsed dendritic cells
12. A mutated β-catenin gene encodes a melanoma-specific antigen recognized by tumor infiltrating lymphocytes
13. The intronic region of an incompletely spliced gp 100 gene transcript encodes an epitope recognized by melanoma-reactive tumor-infiltrating lymphocytes
14. Immunologic and therapeutic evaluation of a synthetic peptide vaccine for the treatment of patients with metastatic melanoma
15. Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer
16. IFN-γ gene transfer restores HLA-class I expression and MAGE-3 antigen presentation to CTL in HLA-deficient small cell lung cancer
17. A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma
18. A peptide encoded by human gene MAGE-3 and presented by HLA-A2 induces cytolytic T lymphocytes that recognize tumor cells expressing MAGE-3
19. Induction of HLA-A2-restricted CTLs to the mucin I human breast cancer antigen
20. Expression of the MAGE gene family and metastatic human breast cancer: Implication for tumor antigen-specific immunotherapy
21. Prediction of response to antiestrogen therapy in advanced breast cancer patients by pretreatment circulating levels of extracellular domain of the HER-2/c-neu protein
22. A gene coding for a protein possessing shared tumor epitopes capable of inducing cytotoxic T lymphocytes in cancer patients
23. + tumors